These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34632819)

  • 1. Relationships Between Socioeconomic Status, Insurance Coverage for Diabetes Technology and Adverse Health in Patients With Type 1 Diabetes.
    Everett EM; Wisk LE
    J Diabetes Sci Technol; 2022 Jul; 16(4):825-833. PubMed ID: 34632819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic status and diabetes technology use in youth with type 1 diabetes: a comparison of two funding models.
    Lomax KE; Taplin CE; Abraham MB; Smith GJ; Haynes A; Zomer E; Ellis KL; Clapin H; Zoungas S; Jenkins AJ; Harrington J; de Bock MI; Jones TW; Davis EA
    Front Endocrinol (Lausanne); 2023; 14():1178958. PubMed ID: 37670884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes.
    Willi SM; Miller KM; DiMeglio LA; Klingensmith GJ; Simmons JH; Tamborlane WV; Nadeau KJ; Kittelsrud JM; Huckfeldt P; Beck RW; Lipman TH;
    Pediatrics; 2015 Mar; 135(3):424-34. PubMed ID: 25687140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Socioeconomic Disparities in Pump Uptake Among Children With Type 1 Diabetes in 2 Canadian Provinces With Different Payment Models.
    Ladd JM; Sharma A; Rahme E; Kroeker K; Dubé M; Simard M; Plante C; Blais C; Brownell M; Rodd C; Nakhla M
    JAMA Netw Open; 2022 May; 5(5):e2210464. PubMed ID: 35507342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing healthcare disparities and managed care considerations with continuous glucose monitoring.
    McAdam-Marx C
    Am J Manag Care; 2022 Jul; 28(4 Suppl):S76-S84. PubMed ID: 36007237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
    Foster NC; Beck RW; Miller KM; Clements MA; Rickels MR; DiMeglio LA; Maahs DM; Tamborlane WV; Bergenstal R; Smith E; Olson BA; Garg SK
    Diabetes Technol Ther; 2019 Feb; 21(2):66-72. PubMed ID: 30657336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population.
    Bratke H; Margeirsdottir HD; Assmus J; Njølstad PR; Skrivarhaug T
    Diabetes Ther; 2021 Sep; 12(9):2571-2583. PubMed ID: 34389930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and limitations of continuous glucose monitoring in type 1 diabetes.
    Stone JY; Bailey TS
    Expert Rev Endocrinol Metab; 2020 Jan; 15(1):41-49. PubMed ID: 31928104
    [No Abstract]   [Full Text] [Related]  

  • 11. Perceptions of Diabetes Technology Use in Cystic Fibrosis-Related Diabetes Management.
    Marks BE; Kilberg MJ; Aliaj E; Fredkin K; Hudson J; Riva D; Román C; Kelly A; Putman MS
    Diabetes Technol Ther; 2021 Nov; 23(11):753-759. PubMed ID: 34185606
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes Technology Experiences Among Latinx and Non-Latinx Youth with Type 1 Diabetes.
    Tsai D; Flores Garcia J; Fogel JL; Wee CP; Reid MW; Raymond JK
    J Diabetes Sci Technol; 2022 Jul; 16(4):834-843. PubMed ID: 34225480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes.
    Lin MH; Connor CG; Ruedy KJ; Beck RW; Kollman C; Buckingham B; Redondo MJ; Schatz D; Haro H; Lee JM; Tamborlane WV; Wood JR;
    Diabetes Technol Ther; 2013 Nov; 15(11):929-34. PubMed ID: 23869706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving pediatric endocrinology trainees' knowledge about insulin pumps and continuous glucose monitors with online spaced education: Technology Knowledge Optimization in T1D (TeKnO T1D).
    Marks BE; Waldman G; Reardon K; Terrio S; Kumar A; Stafford DEJ; Garvey KC; Wolfsdorf JI
    Pediatr Diabetes; 2020 Aug; 21(5):814-823. PubMed ID: 32222056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy of Technology in Type 1 Diabetes: A Systematic Review, Network Meta-analysis, and Narrative Synthesis.
    Pease A; Lo C; Earnest A; Kiriakova V; Liew D; Zoungas S
    Diabetes Technol Ther; 2020 May; 22(5):411-421. PubMed ID: 31904262
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial Disparities in Access and Use of Diabetes Technology Among Adult Patients With Type 1 Diabetes in a U.S. Academic Medical Center.
    Kanbour S; Jones M; Abusamaan MS; Nass C; Everett E; Wolf RM; Sidhaye A; Mathioudakis N
    Diabetes Care; 2023 Jan; 46(1):56-64. PubMed ID: 36378855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Blood Glucose Monitoring Increases Vigorous Physical Activity Levels and Is Associated With Reduced Hypoglycemia Avoidance Behavior In Youth With Type 1 Diabetes.
    Jabbour G; Bragazzi NL
    Front Endocrinol (Lausanne); 2021; 12():722123. PubMed ID: 34557162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations Between Socioeconomic Status and Patient Experience With Type 1 Diabetes Management and Complications: Cross-sectional Analysis of a Cohort From Québec, Canada.
    Talbo MK; Katz A; Dostie M; Legault L; Brazeau AS
    Can J Diabetes; 2022 Aug; 46(6):569-577. PubMed ID: 35864032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.